Medora M. Hardy
- Molecular Biology
- Pharmacology top 5%
- Physiology top 10%
- Immunology
- Rheumatology top 5%
- Co-authors
- Catherine S. TrippChristiaan LeeuwenburghStanley L. HazenShuji Oh‐ishiPeter D. WagnerJay W. HeineckeUrs P. SteinbrecherAlane Koki
- Topics
- Inflammatory mediators and NSAID effects (5 papers)Asthma and respiratory diseases (2 papers)NF-κB Signaling Pathways (2 papers)
- Cited by
- BiochemistryPharmacology
- Journals
- Journal of Biological ChemistryJournal of Pharmacology and Experimental TherapeuticsJournal of Investigative Dermatology
- Partner nations
- United StatesCanada
In The Last Decade
Medora M. Hardy
11 papers receiving 966 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 310
- Pharmacology 251
- Physiology 245
- Immunology 214
- Rheumatology 179
Countries citing papers authored by Medora M. Hardy
This map shows the geographic impact of Medora M. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Medora M. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Medora M. Hardy more than expected).
Fields of papers citing papers by Medora M. Hardy
This network shows the impact of papers produced by Medora M. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Medora M. Hardy. The network helps show where Medora M. Hardy may publish in the future.
Co-authorship network of co-authors of Medora M. Hardy
This figure shows the co-authorship network connecting the top 25 collaborators of Medora M. Hardy. A scholar is included among the top collaborators of Medora M. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Medora M. Hardy. Medora M. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 31 | |
| 3 | 38 | |
| 4 | 30 | |
| 5 | 18 | |
| 6 | 130 | |
| 7 | 29 | |
| 8 | 268 | |
| 9 | 12 | |
| 10 | 378 | |
| 11 | 7 |
About Medora M. Hardy
Medora M. Hardy is a scholar working on Pharmacology, Toxicology and Cancer Research, having authored 11 papers that have together received 977 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Asthma and respiratory diseases (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Biochemistry (120 citations), Pharmacology (251 citations) and Biochemistry (86 citations). Medora M. Hardy has collaborated with scholars based in United States and Canada. Frequent co-authors include Catherine S. Tripp, Christiaan Leeuwenburgh, Stanley L. Hazen, Shuji Oh‐ishi, Peter D. Wagner, Jay W. Heinecke, Urs P. Steinbrecher, Alane Koki, Pamela T. Manning and Mark G. Currie. Their work appears in journals such as Journal of Biological Chemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Investigative Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.